What are cancer clinical trials about: a webinar for you

Today, Larry and I were joined by Evan Denhart in presenting a webinar about clinical trials.  In the two part discussion we talked about clinical trials, what they are, how they work, and what it is like to participate.  Then we discussed the AFFINITY study, a newly launched phase III clinical trial for advanced prostate cancer.  We took questions and had a great time.  See and hear it all here.  This presentation takes a while, so you can preview it quickly, but you will need to set aside a bit of time to get the most out of it.  Hope you enjoy it.

To put a smile on your face see Larry's latest cartoon.
To learn more about clinical trials, take a look at our book.

(c) 2012 Tom Beer and Larry Axmaker

Video: Latest Developments in Advanced Prostate Cancer Treatment with Dr. Beer

A comprehensive discussion on all the principal current treatments and the most promising emerging drugs for advanced prostate cancer.  In this talk, we discuss hormonal agents including abiraterone and MDV-3100, chemotherapy drugs including docetaxel and cabazitaxel, immunologic therapy with sipuleucel-T, biologic therapy with XL-184, and bone targeted therapy with alpharadin.  We then put it altogether to offer a vision for the treatment paradigm of the near future.


For those of you that watched the previously posted talk, this one is a bit more inclusive and comprehensive.  It is a different program that was put together with the team at Medscape.

To see the entire program and slides, you will need to go the Medscape website.  You will likely need to sign up to be a member of Medscape to get full access to these materials.  There is no cost to doing this.


To learn more about clinical trials, take a look at our book.
To put a smile on your face see Larry's latest cartoon.


(c) 2012 Tom Beer and Larry Axmaker